| Dr Anna Edhegard, MD | |
|
109 E Fleming Dr Ste 106, Morganton, NC 28655-3799 | |
| (828) 475-2646 | |
| Not Available |
| Full Name | Dr Anna Edhegard |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 109 E Fleming Dr Ste 106, Morganton, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164657391 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD041179 (District Of Columbia) | Secondary |
| 207N00000X | Dermatology | 2020-03326 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foothills Family Dermatology | 5698176485 | 2 |
News Archive
A new report by Janet Fleischman of the Center for Strategic & International Studies, titled "The Global Health Initiative in Malawi: New Approaches and Challenges to Reaching Women and Girls," examines the U.S. Global Health Initiative (GHI) in Malawi, stating, "The GHI team in Malawi has identified the health of women and girls, including HIV and family planning (FP)/reproductive health (RH) services, as critical, promising areas for GHI success."
When predicting future global population growth, sometimes scientists look to the past. Using a database with historical records that began in 871 A.D., an anthropologist at the University of Missouri was able to show reproductive patterns and shed new light on the "quantity-quality" trade-off, a biological concept used to describe a parent's unconscious decisions to balance between the time and financial investment needed to produce offspring.
New figures published by Dr Foster* in this week's BMJ outline drug and alcohol related harm in the population of England.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.
A novel bandage alerts the nursing staff as soon as a wound starts healing badly. Sensors incorporated into the base material glow with a different intensity if the wound's pH level changes. This way even chronic wounds could be monitored at home.
› Verified 7 days ago
| Entity Name | Foothills Family Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043811128 PECOS PAC ID: 5698176485 Enrollment ID: O20210630003191 |
News Archive
A new report by Janet Fleischman of the Center for Strategic & International Studies, titled "The Global Health Initiative in Malawi: New Approaches and Challenges to Reaching Women and Girls," examines the U.S. Global Health Initiative (GHI) in Malawi, stating, "The GHI team in Malawi has identified the health of women and girls, including HIV and family planning (FP)/reproductive health (RH) services, as critical, promising areas for GHI success."
When predicting future global population growth, sometimes scientists look to the past. Using a database with historical records that began in 871 A.D., an anthropologist at the University of Missouri was able to show reproductive patterns and shed new light on the "quantity-quality" trade-off, a biological concept used to describe a parent's unconscious decisions to balance between the time and financial investment needed to produce offspring.
New figures published by Dr Foster* in this week's BMJ outline drug and alcohol related harm in the population of England.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.
A novel bandage alerts the nursing staff as soon as a wound starts healing badly. Sensors incorporated into the base material glow with a different intensity if the wound's pH level changes. This way even chronic wounds could be monitored at home.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anna Edhegard, MD Po Box 3583, Morganton, NC 28680-3583 Ph: (828) 475-2646 | Dr Anna Edhegard, MD 109 E Fleming Dr Ste 106, Morganton, NC 28655-3799 Ph: (828) 475-2646 |
News Archive
A new report by Janet Fleischman of the Center for Strategic & International Studies, titled "The Global Health Initiative in Malawi: New Approaches and Challenges to Reaching Women and Girls," examines the U.S. Global Health Initiative (GHI) in Malawi, stating, "The GHI team in Malawi has identified the health of women and girls, including HIV and family planning (FP)/reproductive health (RH) services, as critical, promising areas for GHI success."
When predicting future global population growth, sometimes scientists look to the past. Using a database with historical records that began in 871 A.D., an anthropologist at the University of Missouri was able to show reproductive patterns and shed new light on the "quantity-quality" trade-off, a biological concept used to describe a parent's unconscious decisions to balance between the time and financial investment needed to produce offspring.
New figures published by Dr Foster* in this week's BMJ outline drug and alcohol related harm in the population of England.
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today announced the completion of patient follow-up in the Company's pivotal Phase III, Investigational Device Exemption (IDE) clinical trial with dermaPACE™ for the treatment of diabetic foot ulcers.
A novel bandage alerts the nursing staff as soon as a wound starts healing badly. Sensors incorporated into the base material glow with a different intensity if the wound's pH level changes. This way even chronic wounds could be monitored at home.
› Verified 7 days ago
Kim D Edhegard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 109 E Fleming Dr Ste 106, Morganton, NC 28655 Phone: 828-475-2646 | |
Dr. Thomas James Baden, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 111 Foothills Dr, Morganton, NC 28655 Phone: 828-438-4683 Fax: 828-438-4608 |